ISS Updates Its US Proxy Voting Research Procedures & Policies FAQs

by White & Case LLP

White & Case LLP

On March 29, 2018, Institutional Investor Services ("ISS") updated its US Proxy Voting Research Procedures & Policies frequently asked questions ("FAQs")1 . While the 2018 US proxy season is well underway, these updated FAQs provide helpful information to companies, particularly with respect to engagement with ISS' research analysts, as they prepare for the receipt of their ISS reports in advance of their upcoming shareholder meetings.

Engagement with the ISS Research Team

ISS specified the following with respect to engaging with its research team:

Contacting ISS

Companies requesting an engagement should email the Research Helpdesk ([email protected]) and should include: (i) a detailed agenda for the engagement; (ii) a list of the company's participants;2 and (iii) the company's preferred dates/times.


ISS Discretion

ISS has sole discretion to accept engagements and to determine whether the engagement is conducted in person or by phone. It is recommended that companies plan as early as possible for any desired engagement scheduling.

Blackout Periods

The research team is never in a "blackout" with respect to contact with companies or other parties. There is a blackout period for ISS Corporate Solutions, Inc. ("ICS")—the group at ISS that provides advice to companies about governance practices and compliance with ISS guidelines—during the period from the filing of the proxy statement through the date of the shareholder meeting (when information is analyzed and voting recommendations are made).

In addition, Governance QualityScore data verification is closed from the filing of the proxy until the publication of the ISS proxy report.

Timing and Priority for Non-Contentious Meetings

For engagements regarding non-contentious meetings, the preferred time to schedule engagements is August through February. Engagements relating to ISS' new policies should be scheduled after the release of the ISS policy updates in November. Most non-contentious engagements take place prior to the filing of the proxy materials; once the proxy is filed, ISS will generally be able to undertake engagement with the company only where it is necessary and appropriate, and usually only to clarify points on which it has questions. ISS prioritizes engagements with companies with substantive governance issues: for example, companies facing low shareholder support on their sayon-pay or director elections, majority-supported shareholder proposals, ISS recommendations against management proposals at the prior election, or companies undergoing major transitions.

Timing and Priority for Contentious Meetings

For proxy fights or contested mergers, ISS will generally engage with both sides once the proxy materials are released. ISS will reach out directly to schedule the engagements and generally will offer each side an equal opportunity for engagement. In general, ISS will schedule the engagement with the dissident side first to identify the areas of contention, and to give the company the opportunity to respond to the dissident's arguments. Follow-up meetings may also be scheduled.

Engagement with Respect to Vote-No Campaigns

A vote-no campaign against directors may be considered sufficiently contentious to warrant engagement. ISS will review the materials and, if it determines that further engagement is warranted, will reach out to both sides. The voteno campaign must be via Edgar filings (e.g., an exempt filing) to warrant such consideration; postings on the dissenting shareholders' website would be insufficient.

Information for Discussion

Public Information Only

The FAQs reiterate that all discussions with ISS are on-the-record, material non-public information should not be disclosed and information provided by companies during engagements with ISS should either be already publiclyavailable to all shareholders or will be disclosed in the filings for the company's upcoming shareholder meeting. ISS accepts no obligation of confidentiality with respect to matters discussed during engagements.

Firewall between ISS Research and ICS

Companies should not: (i) disclose any past, present or expected contact with ICS or its personnel; (ii) disclose or discuss any information obtained from the purchase of ICS services or products; or (iii) identify the company, either directly or indirectly, as an ICS client (or prospective client). Doing so could result in the immediate termination of discussions.

No Consultation or Advice

ISS research analysts cannot offer any advice to the company and no statement made during an engagement should be construed as an indication of how ISS will recommend in a given situation or on a specific proposal.

Other Updates

  • Methods of Providing Additional Information After Publication of an ISS Report: Previously, a company that wanted to make changes or provide additional information to shareholders after an ISS proxy report had been published was required to publicly disclose the information in a filing with the Securities and Exchange Commission ("SEC") or, if the company was not an SEC filer, in a press release. The updated FAQs clarify that for information that is normally not included in a filed document and only resides on the company's website, such as corporate governance guidelines or environmental reports, the information can be made public in a press release or on the company website (i.e., even if the company is an SEC filer).
  • Exceptions to the Attendance Policy for Newly-Appointed Directors: Given that newly-appointed directors will not have had the benefit of advance notification of scheduled meetings, they are generally exempted from a negative vote recommendation if such newly-appointed director attended fewer than 75% of the aggregate of the board and committee meetings for the period for which they served, or if the disclosure with respect to such newly-appointed director's attendance record is otherwise unclear as to whether they attended 75% of their meetings.
  • Evaluation of a Board's Implementation of Proxy Access in Response to a Majority-Supported Shareholder Proposal: The FAQs clarified that board-implemented proxy access provisions, which provide the board with broad and binding authority to interpret the provision, while problematic, may not void the right on its own but would be considered in connection with other problematic provisions.
  • Poison Pills:
    • ISS' policy for 2018 is to recommend against director nominees at companies with non-shareholder approved pills that are in effect as of the date of the shareholder meeting (any such poison pills will not be grandfathered under the new policy). Further, ISS still considers "deadhand" or "slowhand" provisions3 problematic.
    • In order to terminate a poison pill prior to its expiration date, most companies can accelerate the pill's expiration date, which does not involve the costs of redemption.
  • Charter/Bylaw Adoptions at Newly Public Companies: For newly-public companies, the adoption of a multiclass structure, 4 classified board, and/or supermajority vote requirements will generally result in the continued withhold/against recommendations by ISS. Fee-shifting provisions also result in continued withhold recommendations.
  • Governance Failures Policy: The FAQs explain that the Governance Failures policy is designed to catch isolated egregious actions that are not covered under other policies. If a type of action applies to a large number of companies, or persists year after year, ISS will generally break this out as its own, standalone policy. For example, unilateral bylaw amendments that diminish shareholders' rights, excessive pledging, and failure to opt out of state statutes requiring a classified board (Indiana and Iowa) previously fell under the Governance Failures policy umbrella, but a sharp increase in the incidence of unilateral bylaw amendments and the related issue of companies going public with poor governance structure caused ISS to separate these issues out as a standalone policy for 2015. Similarly, in 2018, ISS further separated out excessive pledging and the failure to opt out of state statutes requiring a classified board as standalone policies.

Click here to download PDF

1 The FAQs are available here.
2 ISS prefers that one or more board members take part in any discussion. Any discussion with ISS will center on the company’s long-term focus and strategy and how it drives decision-making to satisfy shareholder objectives.
3 A “deadhand” provision in a poison pill stipulates that only persons who were members of the board of directors at the time the poison pill was put into place (i.e., continuing directors) have the power to rescind it. A “slowhand” provision prevents a poison pill from being redeemed for a specified period of time after a change in board composition.
4 In recent speeches, SEC Chairman, Jay Clayton, has expressed a contrasting view on the importance of the issue of dual-class structures, stating that they were not at the “front of the agenda for something [the SEC] should weigh in on” and that there are more pressing issues to investors and the marketplace. He also expressed that he is “not persuaded by absolutists on either end” of the dual-class share issue and that “governance by indexation,” or removing companies from indexes because of their voting share structures, does not sit well with him.

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© White & Case LLP | Attorney Advertising

Written by:

White & Case LLP

White & Case LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.